NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Organogenesis Holdings Inc.
Filed:
2026-04-24
AccNo:
0002064832-26-000183
Size:
6 KB
发布时间04/25 01:29 UTC
首次发现04/25 01:32 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 584 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0002064832-26-000183
Filing Date: 2026-04-24
Accepted: 2026-04-24 21:29:49
Documents: 1
Period of Report: 2025-01-10
Organogenesis Holdings Inc. ( Issuer ) CIK : 0001661181 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | form4.html | 4
1 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | form4.xml | 4